Yes. This is the first audit where I would say the repository is **ready for the authoritative real-data run**.

PR #19 addresses the eight remaining pre-run issues: strict manifest validation, incremental-vs-marginal semantics, removal of LRT gating, documented interpretation thresholds, research-grade bootstrap defaults, resumable embeddings, simulation-safe wording, and roadmap reconciliation. The PR reports 170 passing tests and clean `basedpyright`.

## Re-audit verdict

| Previous issue                                               | Status                |
| ------------------------------------------------------------ | --------------------- |
| Malformed/incomplete manifests can pass real mode            | **Fixed**             |
| Stage 11 uses marginal B-vs-A metrics for incremental claims | **Fixed**             |
| Development LRT gates H4                                     | **Fixed**             |
| H1/H2 interpretation conventions undocumented                | **Mostly fixed**      |
| Real bootstrap count too small                               | **Fixed**             |
| Stage 10 capped at 20 bootstraps                             | **Fixed**             |
| Embedding checkpoints don't resume                           | **Fixed**             |
| Simulation reports sound empirical                           | **Fixed**             |
| Roadmap confuses code completion with empirical completion   | **Fixed**             |
| Authoritative real run                                       | **Now the next step** |

The roadmap now correctly separates `[code]` completion from `[data]` execution. In particular, Stage 8–11 remain explicitly pending at the empirical-data level instead of pretending the simulation reports complete those stages.

The committed Stage 9 report also remains clearly labeled **SIMULATION — NOT EMPIRICAL RESULTS**, now calls itself an “analysis demonstration,” and uses the held-out incremental \(A+B\) versus \(A\) quantity for H4.

## The main statistical fixes are correct

H4 now uses:

$$
\Delta AUROC
=
AUROC(A+B)-AUROC(A)
$$

with the held-out bootstrap CI as the governing inferential quantity. The development-set LRT is retained only as descriptive supporting information. That now agrees with the proposal itself.

Stage 11 was also changed to use the actual incremental quantities—`incremental.auroc_improvement`, `incremental.brier_improvement`, and held-out loss reduction—instead of confusing them with standalone \(B-A\) performance. The PR explicitly documents that correction.

Bootstrap behavior is now appropriate for the real study: real mode defaults to **1,000 patient-level bootstrap resamples**, while simulation remains lightweight at 50; the prior Stage 10 cap at 20 has been removed.

## Checkpoint resume is now real

The embedding extraction no longer merely writes checkpoint files. It restores embeddings and validity flags and resumes from `processed_count`, while checking a deterministic cohort hash, model name, and embedding dimensionality.

That's particularly important for the ~161k-record D-BETA run.

One small improvement I'd still make eventually: the checkpoint fingerprint currently checks the **model name**, but D-BETA itself is pinned to a specific Hugging Face revision (`20ff3cc...`).  Ideally the checkpoint should also encode:

```text
model_version
preprocessing configuration
lead order
target sampling rate
target signal length
normalization setting
```

Then a preprocessing or model-revision change cannot accidentally reuse stale embeddings.

I would call this **non-blocking**, since the current model revision is pinned.

## Provenance is now fail-closed by default

The prior malformed-manifest hole has been explicitly closed. Real mode now rejects:

* malformed JSON;
* non-object JSON;
* missing `data_mode`;
* missing prediction SHA-256;
* checksum mismatch;

unless the user deliberately supplies the unverified-artifact override. Tests were added for these cases.

There is only one small provenance-design refinement I would consider later: when `--allow-unverified-artifact` is deliberately used, I would have downstream reports say:

> **UNVERIFIED ARTIFACT**

rather than infer “REAL” merely from the requested execution mode.

The default path is safe, so this is not a reason to hold up the real run.

## One proposal/code convention should be clarified

This is the only methodological mismatch I noticed that I would fix before manuscript-level interpretation.

The proposal now says H2 uses:

> gradient ratio \(T_3/T_1 \ge 1.50\) **or positive risk difference**

as a descriptive benchmark.

But the implementation's H2 verdict is still fundamentally built around the **1.50× gradient threshold**. The current simulation report reflects that wording exactly.

I would remove the parenthetical “or positive risk difference” from the proposal unless you truly intend any positive RD to constitute “meaningful residual risk.” Merely observing:

$$
RD>0
$$

without an uncertainty criterion is too permissive anyway.

A cleaner prespecified rule is:

> 1.50× is a descriptive effect-size benchmark; bootstrap RD/RR intervals communicate uncertainty.

This is documentation cleanup, not a pipeline blocker.

## One terminology point

The proposal says weak correlation means the representations are “largely orthogonal.”

I'd soften that to:

> “weakly rank-aligned”

because low Spearman correlation does not mathematically establish orthogonality of the underlying learned representations.

Again, minor.

## Testing confidence

The merged PR states:

* `170 passed`
* `basedpyright`: 0 errors, 0 warnings
* successful end-to-end `pipeline --simulate`

I did not find a GitHub Actions run associated with the merge commit, so those execution results are repository-reported/local rather than independently visible CI evidence. That doesn't concern me much for a protected MIMIC workflow, but a lightweight GitHub Actions job running public synthetic tests could be useful later.

# Recommendation: run it

I would stop iterating on audit-driven architecture now.

The remaining issues are all small enough to handle afterward. Repeatedly polishing infrastructure before observing a single real output now has diminishing returns.

I would run the real Stage 8 pipeline with the pinned D-BETA checkpoint and a protected checkpoint path, for example:

```bash
uv run ecg-alignment pipeline \
  --mimic-root ~/data/mimiciv/3.1 \
  --ecg-root ~/data/mimic-iv-ecg/1.0 \
  --n-bootstraps 1000 \
  --checkpoint-path ~/data/ecg-model-alignment/dbeta-embeddings.npz
```

For the real audit afterward, the first things I would inspect are **not** AUROCs. I would start with:

1. the run manifest and exact D-BETA revision;
2. Model A/B technical failure counts;
3. CIIS distribution in the real cohort;
4. D-BETA probability/logit distribution;
5. train/validation/test event counts;
6. probe validation behavior and selected \(C\);
7. calibration sanity;
8. then H1–H4.

That next pass should finally be a **scientific results audit**, rather than another software-provenance audit.

My present verdict is therefore:

> **Pre-run audit: PASS, with minor non-blocking cleanup notes. Proceed to authoritative empirical execution.**
